Navigation Menu

Skip to Navigation menu Skip to top of page

19 June 2008

Biotech industry growth to slow

Eklavya Gupte, London

The biotech industry is set to slow down because of funding pressures and competition from biosimilars, according to two reports launched this week

The IMS 2008 Global Biotech Perspective report published on June 17 by IMS Health says that global prescription sales of biotech drugs increased 12.5% in 2007 to more than $75 billion.




The rest of this article is available to subscribers to Managing IP only.

Managing IP subscribers also have access to Managing Patents, Trade marks and Copyright until 30th October 2010.
Managing IP trialists have access to Managing Patents, Trade marks and Copyright for 48-hours.

Subscribe today for full access to this article. Alternatively, take a 48-hour free trial  giving you access to the current content. 

If you are already a subscriber please log in (see top right column) to access the rest of this article.